Effects of Realistic In Vitro Test Factors on the Aerosol Properties of Metered-Dose Inhalers

Development of generic inhalation products is challenging, and CDER scientists are helping develop more realistic methods using anatomical m

Receive this email as a forward? Subscribe to CDER SBIA industry updates. FDA | CDER | Small Business and Industry Assistance INDUSTRY NEWS . Effects of Realistic In Vitro Test Factors on the Aerosol Properties of Metered-Dose Inhalers   Metered dose inhalers are mainstays in the treatment of asthma, COPD, and other respiratory diseases. Development of generic inhalation products is challenging, and CDER scientists are helping develop more realistic methods using anatomical models of the mouth-throat region that allow the generic industry to efficiently test their products and speed access to generic inhalation products. Learn more about recent research supporting these efforts.   Learn More The Small Business and Industry Assistance (SBIA) program in the Center for Drug Evaluation and Research  provides guidance, education and updates for regulated industry. Subscribe to CDER SBIA Email Updates Register for Upcoming Training View 2021 Recordings on YouTube Follow on LinkedIn Follow on Twitter This is an automated message delivery system. Replying to this message will not reach the CDER SBIA staff. If you have comments or questions, contact us at CDERSBIA@fda.hhs.gov or 1-866-405-5367 or (301) 796-6707.  SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA